Searching over 5,500,000 cases.


searching
Buy This Entire Record For $7.95

Download the entire decision to receive the complete text, official citation,
docket number, dissents and concurrences, and footnotes for this case.

Learn more about what you receive with purchase of this case.

In re Ethicon, Inc. Pelvic Repair Systems Product Liability Litigation

United States District Court, S.D. West Virginia, Charleston Division

March 29, 2017

IN RE ETHICON INC. PELVIC REPAIR SYSTEMS PRODUCT LIABILITY LITIGATION THIS DOCUMENT RELATES TO: Wave 2 s Identified in Exhibit A attached hereto Case and Docket Number Product(s) Case and Docket Number Product(s)

          ORDER ADOPTING MEMORANDUM OPINION AND ORDER (DAUBERT RULING RE: SUZANNE PARISIAN, M.D.)

          JOSEPH R. GOODWIN UNITED STATES DISTRICT JUDGE

         Pending before the court is the defendants' Motion to Exclude the Opinions of Suzanne Parisian, M.D., Relating to the TVT-Secur Device [Wave 2] [ECF No. 2387] filed on July 20, 2016. For reasons appearing to the court, the court ORDERS that the Memorandum Opinion and Order (Daubert Motion re: Suzanne Parisian, M.D.) [ECF No. 2726] (“Prior Order”) entered on September 2, 2016, as to the Ethicon Wave 1 cases is ADOPTED in the Wave 2 cases identified in Exhibit A.[1] The Prior Order is attached hereto as Exhibit B.

         Importantly, the court notes that the expert opinions proffered in Wave 1 are in almost every respect identical to those proffered here. The court has found, however, that with each entered Order, the experts in these cases attempt to bolster or fine-tune the support for their opinions, but the opinions themselves do not change. Accordingly, the court will refrain from engaging in the extremely inefficient practice of continuously reexamining the qualifications, reliability, and relevance of dozens of experts and their numerous opinions. While the parties continue to challenge even the slightest alteration to the underlying support for an expert's opinion, the court's review of the parties' arguments reveals that these refreshed Daubert challenges are different from previous arguments by only the very slightest of degrees. The court FINDS that to the extent that the parties raise arguments not previously addressed by the court's Prior Order, the trial judge may easily resolve these issues at trial without the need for further briefing or an evidentiary hearing. Accordingly, the court ORDERS that to the extent that the parties raise Daubert challenges not previously addressed in the court's Prior Order-fully adopted herein-those challenges are RESERVED for trial.

         The court DIRECTS the Clerk to file a copy of this Order Adopting Memorandum Opinion and Order in 2:12-md-2327 and in the Ethicon Wave 2 cases identified in the Exhibit attached hereto.

         EXHIBIT A

         EXHIBIT A TO DEFENDANTS' MOTION TO EXCLUDE SUZANNE PARISIAN, M.D. [WAVE 2]

         Pursuant to the third Amended Docket Control Order, Defendants submit the following list of cases apply to Defendants' Motion to Exclude Suzanne Parisian, M.D.[1]

         List of Applicable Cases

Case and Docket Number
Product(s)
Higgins, Susan Dye & Bob v. Ethicon, Inc., et ah,
Case No. 2:12-cv-01365
TVT Secur
Sanders, Melissa G. & Charles, Jr. v. Ethicon, Inc., ctal.,
Case No. 2:12 cv 01562
TVT Sccur
Sutton, Martha v. Ethicon, Inc., ctal., Case No. 2:12 cv 01857
TVT Secur

         Dr. Parisian was designated as an expert in the following cases but did not serve a report with respect to the product(s) in issue. On June 21, 2016, the parties entered into a Stipulation whereby Plaintiffs agreed to withdraw Dr. Parisian as a designated expert for these matters. The Stipulation has been filed in each of these individual cases.

Case and Docket Number
Product(s)
McDonald, Maria Elena & Thomas v. Ethicon, Inc., ctal.,
Case No. 2:12 cv 01366
Gyncmcsh PS; TVT Obturator
Slocumb, Kathryn v. Ethicon, Inc. ctal., Case No. 2:12 cv 01974
Prolift Total
Vallc, Maritza v. Ethicon, Inc. ctal., Case No. 2:12 cv 01368
Prolift Total
Zapata, Sandra v. Ethicon, Inc. ctal, Case No. 2:12 cv 01972
Prolift Total
Pippin, Laura & Donald v. Ethicon, Inc. ct al.,
Case No. 2:12 cv 02152
TVT; TVT Obturator

         MEMORANDUM OPINION AND ORDER (DAUBERT MOTION RE: SUZANNE PARISIAN, M.D.)

         Pending before the court is the Motion to Exclude Suzanne Parisian, M.D. [ECF No. 2079] filed by the defendants Ethicon, Inc. and Johnson & Johnson (collectively “Ethicon”). The Motion is now ripe for consideration because briefing is complete.

         I. Background

         This case resides in one of seven MDLs assigned to me by the Judicial Panel on Multidistrict Litigation concerning the use of transvaginal surgical mesh to treat pelvic organ prolapse (“POP”) and stress urinary incontinence (“SUI”). In the seven MDLs, there are more than 75, 000 cases currently pending, approximately 30, 000 of which are in this MDL.

         In this MDL, the court's tasks include “resolv[ing] pretrial issues in a timely and expeditious manner” and “resolv[ing] important evidentiary disputes.” Barbara J. Rothstein & Catherine R. Borden, Fed. Judicial Ctr., Managing Multidistrict Litigation in Products Liability Cases 3 (2011). To handle motions to exclude or to limit expert testimony pursuant to Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), the court developed a specific procedure. In Pretrial Order (“PTO”) No. 217, the court instructed the parties to file only one Daubert motion per challenged expert, to file each motion in the main MDL-as opposed to the individual member cases-and to identify which cases would be affected by the motion. PTO No. 217, at 4.[1]

         II. Preliminary Matters

         Before plunging into the heart of the Motion, a few preliminary matters need to be addressed.

         I am compelled to comment on the parties' misuse of my previous Daubert rulings on several of the experts offered in this case. See generally Sanchez v. Bos. Sci. Corp., No. 2:12-cv-05762, 2014 WL 4851989 (S.D. W.Va. Sept. 29, 2014); Tyree v. Bos. Sci. Corp., 54 F.Supp.3d 501 (S.D. W.Va. 2014); Eghnayem v. Bos. Sci. Corp., 57 F.Supp.3d 658 (S.D. W.Va. 2014). The parties have, for the most part, structured their Daubert arguments as a response to these prior rulings, rather than an autonomous challenge to or defense of expert testimony based on its reliability and relevance. In other words, the parties have comparatively examined expert testimony and have largely overlooked Daubert's core considerations for assessing expert testimony. Although I recognize the tendency of my prior evidentiary determinations to influence subsequent motions practice, counsels' expectations that I align with these previous rulings when faced with a different record are misplaced, especially when an expert has issued new reports and given additional deposition testimony.

         Mindful of my role as gatekeeper for the admission of expert testimony, as well as my duty to “respect[ ] the individuality” of each MDL case, see In re Phenylpropanolamine Prods. Liab. Litig., 460 F.3d 1217, 1231 (9th Cir. 2006), I refuse to credit Daubert arguments that simply react to the court's rulings in Sanchez and its progeny. Indeed, I feel bound by these earlier cases only to the extent that the expert testimony and Daubert objections presented to the court then are identical to those presented now. Otherwise, I assess the parties' Daubert arguments anew. That is, in light of the particular expert testimony and objections currently before me, I assess “whether the reasoning or methodology underlying the testimony is scientifically valid” and “whether that reasoning or methodology properly can be applied to the facts in issue.” Daubert, 509 U.S. at 592-93. Any departure ...


Buy This Entire Record For $7.95

Download the entire decision to receive the complete text, official citation,
docket number, dissents and concurrences, and footnotes for this case.

Learn more about what you receive with purchase of this case.